BackTC BioPharm (Holdings) plc - Warrants (08/02/2027) Overview

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Current Cash

Latest current cash for TCBPW: $1M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$1.00M
↓ 47.65% YoYΔ $-914193.00 vs prior year quarter

Peer average

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Current Cash History

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) vs. peers: Current Cash Comparison

Loading

TC BioPharm (Holdings) plc - Warrants (08/02/2027) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TC BioPharm (Holdings) plc - Warrants (08/02/2027) (TCBPW) FAQ

The latest current cash for TCBPW is $1M as of June 2024. That compares with $1.9M in the prior-year period — down 47.7% year over year. Investors often review this figure alongside TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, TCBPW's current cash moved from $1.9M to $1M — a 47.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in TC BioPharm (Holdings) plc - Warrants (08/02/2027)'s operating scale or balance-sheet position.

A current cash figure of $1M for TCBPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TCBPW's current cash ($1M), review year-over-year change from $1.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.